Exagen Diagnostics' Debt - XVII Round

Exagen Diagnostics raised a round of funding on September 11, 2017. Investors include Innovatus Capital Partners.

Exagen Diagnostics is a Patient Focused, Discovery Driven, CLIA-certified, CAP-accredited laboratory with a growing menu of proprietary, internally developed tests focusing in the area of Rheumatology…

Articles about Exagen Diagnostics' Debt - XVII Round: